Mike Thompson, MD, PhD, FASCO

VP Clinical Partnerships @TempusAI #PrecisionMedicine #mmsm #lymsm #MDSsm #leusm #CCC19 @COVID19nCCC @ASCO COI:

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

Whole Genome Sequencing [WGS] Reveals Novel, Clinically Relevant Biomarkers Missed by Standards of Care for Pts w/ Myelodysplastic Syndrome [MDS] [Jun 11, 2026] @AlexBataller et al. #EHA2026 EHA-4897 PF656 https://t.co/Je6wyHzypT #MDSsm #leusm #cagenome @UTMDAnderson @TempusAI

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - OFIRNOFLAST NEK7i in LR MDS - Bafna #EHA2026 #MDSsm #leusm Conclusions

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - OFIRNOFLAST NEK7i in LR MDS - Bafna #EHA2026 #MDSsm #leusm QoL

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - OFIRNOFLAST NEK7i in LR MDS - Bafna #EHA2026 #MDSsm #leusm

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - OFIRNOFLAST NEK7i in LR MDS - Bafna #EHA2026 #MDSsm #leusm no treatment related SAEs

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - OFIRNOFLAST NEK7i in LR MDS - Bafna #EHA2026 #MDSsm #leusm NLRP3 inflammasome activation drives ineffective hematopoiesis

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - OFIRNOFLAST NEK7i in LR MDS - Bafna #EHA2026 #MDSsm #leusm

[Rahul Banerjee, MD, FACP @RahulBanerjeeMD]

Literally the job I was born for at #EHA2026 - looking forward to learning from @SurbhiSidanaMD @PlasmaCellPete @JHillengass !

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MAXILUS - Luspatercept in LR MDS - Della Porta #EHA2026 #MDSsm #leusm

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - TP53 in MDS - Streuer #EHA2026 #MDSsm #leusm #camoldx #PrecisionMedicine Summary

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - TP53 in MDS - Streuer #EHA2026 #MDSsm #leusm #camoldx #PrecisionMedicine

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - TP53 in MDS - Streuer #EHA2026 #MDSsm #leusm #camoldx #PrecisionMedicine

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - TP53 in MDS - Streuer #EHA2026 #MDSsm #leusm #camoldx #PrecisionMedicine

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - TP53 in MDS - Streuer #EHA2026 #MDSsm #leusm #camoldx #PrecisionMedicine

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

MDS Oral - Clinical - TP53 in MDS - Streuer #EHA2026 #MDSsm #leusm #camoldx #PrecisionMedicine

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

Lymphoma - New Agents - DLBCL - Lenz - #EHA2026 #lymsm #caxtx Conclusions

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

Lymphoma - New Agents - DLBCL - Lenz - #EHA2026 #lymsm #caxtx CLEAR study

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

#EHA2026

[Joshua Richter, MD, FACP @JoshuaRichterMD]

Joining hematology and Severance @EHA_Hematology #mmsm

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

Lymphoma - New Agents - DLBCL - Lenz - #EHA2026 #lymsm #caxtx STARGLO - Glo-Gem-Ox

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

Lymphoma - New Agents - DLBCL - Lenz - #EHA2026 #lymsm #caxtx R-Pola-Glo

[Mike Thompson, MD, PhD, FASCO @mtmdphd]

Lymphoma - New Agents - DLBCL - Lenz - #EHA2026 #lymsm #caxtx frontMIND #NCT04824092